AK, E., HH, P., CE, W., RK, L., DR, R., C, X., . . . M, S. (2024). Impact of noradrenergic inhibition on neuroinflammation and pathophysiology in mouse models of Alzheimer's disease. Journal of neuroinflammation, 21(1), 322. https://doi.org/10.1186/s12974-024-03306-1
Chicago Style (17th ed.) CitationAK, Evans, et al. "Impact of Noradrenergic Inhibition on Neuroinflammation and Pathophysiology in Mouse Models of Alzheimer's Disease." Journal of Neuroinflammation 21, no. 1 (2024): 322. https://doi.org/10.1186/s12974-024-03306-1.
MLA (9th ed.) CitationAK, Evans, et al. "Impact of Noradrenergic Inhibition on Neuroinflammation and Pathophysiology in Mouse Models of Alzheimer's Disease." Journal of Neuroinflammation, vol. 21, no. 1, 2024, p. 322, https://doi.org/10.1186/s12974-024-03306-1.